Rsz New Ausdoc Display Ad Image

3 AusDoc innovations to support your brands, reps and events to achieve maximum HCP engagement

Do you want to boost your lead generation and increase GP touchpoints 6-fold?  The new Access.PLUS Sample and Service requests package has already proved itself with 2,000+ doctor lead generations and 3,000+ sample requests for 10 pharma companies.  The package is designed to improve the efficiency of your field force by generating more touchpoints for

View

Rsz Inside Healthcare Msls Feb 2023

Are MSLs the untapped opportunity for Pharma to better support GPs?

GPs have a low understanding of the difference between medical science liaisons (MSLs) and pharmaceutical sales reps, according to a recent survey conducted by AusDoc.1  The finding is unsurprising, given that MSLs generally focus on other specialists. But the increasing complexity of GP work means they will likely receive increasing MSL attention in the future. 

View

Rsz Omnichannel Veeva Report

Putting an Aussie lens on Veeva’s global omnichannel report

The recent Veeva Pulse Field Trends Report 2Q22[i] provided valuable insight into when, where and how field teams and healthcare professionals interact with the pharmaceutical industry representatives. However, the global report didn’t’ offer any Australia-specific findings. To fill this gap, Inside Healthcare conducted a similar study among AusDoc’s extensive GP database to provide deeper insights

View

Rsz New Ausdoc Display Ad Image

Discover better with the new AusDoc community platform

AusDoc has become a whole lot better.   We are evolving into a community platform, allowing doctors to connect with their colleagues across the medical profession as well as keeping them informed with the latest news, opinion, clinical updates and education.  Given the ever-growing complexity of medicine, a community where doctors can discuss and debate the

View

Condundrum Report Image

How can pharma companies fill the gap in digital delivery?

Global report shows excitement about the potential of digital but a lack of confidence about delivery Pharma companies need to invest in the digital customer experience to add value now and in the future, according to a report by digital customer experience agency Graphite in partnership with Reuters Events. The global report titled the Contradiction Conundrum is

View

Inside Healthcare Mrec

How to cover twice as many GPs without increasing your budget

A hybrid model that combines reps with digital solutions is a win-win for pharmaceutical companies and GPs. With face-to-face rep engagement returning to pre-COVID levels, pharmaceutical companies have an opportunity to use digital lessons learned during the pandemic to significantly increase the reach and frequency of their GP interactions without increasing their budget. The solution

View

Native Digital Dr

Developing new communication strategies for the digital native doctor

About one in three Australian GPs is a digital native,1 which has fundamental implications for go-to-market strategies and a critical impact on how pharmaceutical companies promote the quality use of their medicines. Digital natives were born after 1980 and raised in an environment in which they were surrounded by technology (Palfrey and Gasser, 2013, Prensky, 2001).

View

Rsz Gp Reading Outside Working Hours

Why engaging with GPs outside of working hours is crucial for pharma

Australian prescribers have tasted digital convenience and are unlikely to return to their pre-pandemic levels of face-to-face engagement with pharmaceutical representatives. That’s according to an in-depth report published by ADG in 2021 and a follow-up pulse survey among Australian Doctor readers conducted in January 2022[i]. The report titled How a GP initiated engagement model could

View